<< Back To Bloggers

Overview

Food and Drug Administration (FDA)

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Articles

Secondhand (and Third-Hand) Smoke Increases Your Pet’s Cancer Risk

Did you know? A cat who lives with a pack-a-day smoker is three times more likely to develop lymphoma.

FDA Approves Lenvima Plus Keytruda for Advanced Kidney Cancer

Targeted therapy and immunotherapy combination doubles response rate for people with advanced renal cell carcinoma.

FDA Grants First Full Approval for Treatment of Lymphoma in Dogs

Lymphoma, also called lymphosarcoma, is a type of cancer that can affect many species, including dogs.

FDA Approves Rylaze for Leukemia and Lymphoma

New recombinant drug may be an option for patients with hypersensitivity to standard asparaginase chemotherapy.

FDA Encourages Inclusion of People With Incurable Cancers in Clinical Trials

FDA Ayvakit for Advanced Systemic Mastocytosis

hand with green ribbon cerebral palsy and liver cancer awareness

FDA Approves Truseltiq for Metastatic Cholangiocarcinoma

New targeted therapy shrank tumors in nearly a quarter of patients with bile duct cancer.

FDA Approves Opdivo for Resected Esophageal Cancer

Checkpoint inhibitor doubled disease-free survival time after surgery.

esophagus, throat, stomach, gastric, digestive tract

FDA Approves Keytruda for HER2-Positive Stomach Cancer

75% of people treated with a combination of immunotherapy, targeted therapy and chemotherapy saw their tumors shrink.

Hot topics

Breast Cancer

Lung Cancer

Liver Cancer

Prostate Cancer

Cancer Treatment

Cancer Screening

Ovarian Cancer

Blood Cancers - Leukemia/Lymphoma/Multiple Myeloma

FDA Authorizes First Device that Uses Artificial Intelligence to Help Detect Colon Cancer

The GI Genius aids clinicians in detecting potential irregularities during colon cancer screening and surveillance.

FDA Approves New Targeted Therapy for Lymphoma

Zynlonta led to complete remission in nearly a quarter of patients with large B-cell lymphoma.

FDA Approves Immunotherapy for Endometrial Cancer with Specific Biomarker

New checkpoint inhibitor Jemperli is approved for cancers with deficient mismatch repair mechanism for fixing damaged DNA.

FDA Approves First Immunotherapy for Initial Treatment of Stomach Cancer

Opdivo plus chemotherapy led to a significant improvement in overall survival.

FDA Approves New Sarclisa Regimen for Multiple Myeloma

The monoclonal antibody reduces the risk of disease progression or death by 45%.

Yescarta, CAR-T, axicabtagene ciloleucel

FDA Approves Yescarta for Follicular Lymphoma

The CAR-T therapy led to complete remission in 60% of people with relapsed or refractory follicular lymphoma.

FDA Approves Lorbrena for Metastatic ALK-Positive Lung Cancer

The targeted therapy delayed disease progression in people with advance non-small-cell lung cancer, including those with brain metastasis.

FDA Approves Pepaxto for Heavily Treated Multiple Myeloma

Nearly a quarter of patients treated with the peptide-drug conjugate experienced partial remission.

FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy

Cosela (trilaciclib) is given before chemotherapy to protect bone marrow function.